AstraZeneca: to present developments in anti-cancer drugs
(CercleFinance.com) - AstraZeneca will present new developments in its cancer drugs at the 2020 Virtual Congress of the European Society of Medical Oncology (ESMO) from 19 to 21 September.
"AstraZeneca medicines and pipeline molecules feature in 114 abstracts at ESMO, a record for the Company, including 20 oral presentations and two Presidential Symposia," it said.
"The data highlight the breadth of the portfolio of cancer medicines and the early-stage pipeline".
Copyright (c) 2020 CercleFinance.com. All rights reserved.
"AstraZeneca medicines and pipeline molecules feature in 114 abstracts at ESMO, a record for the Company, including 20 oral presentations and two Presidential Symposia," it said.
"The data highlight the breadth of the portfolio of cancer medicines and the early-stage pipeline".
Copyright (c) 2020 CercleFinance.com. All rights reserved.